BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17249857)

  • 21. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
    Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
    BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.
    Dommasch ED; Joyce CJ; Mostaghimi A
    JAMA Dermatol; 2017 Sep; 153(9):874-881. PubMed ID: 28636704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost.
    Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Muthukumar A; Devine F; Sundar M; Bogart M; Hagopian E; Poston S; Duh MS; Oppenheimer JJ
    BMJ Open Respir Res; 2024 Jun; 11(1):. PubMed ID: 38862238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
    Mehra M; Hill K; Nicholl D; Schadrack J
    J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care utilization and cost burden of herpes zoster in a community population.
    Yawn BP; Itzler RF; Wollan PC; Pellissier JM; Sy LS; Saddier P
    Mayo Clin Proc; 2009 Sep; 84(9):787-94. PubMed ID: 19720776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
    Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
    J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review.
    Gater A; Uhart M; McCool R; Préaud E
    BMC Public Health; 2015 Feb; 15():193. PubMed ID: 25880058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity and cost related to hospital management of herpes zoster in France: focus on ophthalmic herpes zoster].
    Berrut G; Vainchtock A; Fernandez J; Bresse X; Baptiste C; De Decker L
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Dec; 12(4):395-401. PubMed ID: 25515904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.
    Chung SD; Ho JD; Lin HC; Kao LT; Tsai MC
    J Glaucoma; 2015; 24(5):e116-20. PubMed ID: 25642815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.
    Insinga RP; Ng-Mak DS; Hanson ME
    Cephalalgia; 2011 Nov; 31(15):1570-5. PubMed ID: 22013140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapies for herpes zoster infections. Are they economically justifiable?
    Smith KJ; Roberts MS
    Pharmacoeconomics; 2000 Aug; 18(2):95-104. PubMed ID: 11067653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of herpes zoster and postherpetic neuralgia in the United States.
    Weaver BA
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study.
    Song H; Lee J; Lee M; Choi WS; Choi JH; Lee MS; Hashemi M; Rampakakis E; Kawai K; White R; Acosta C; Sampalis JS; Cheong HJ
    Int J Infect Dis; 2014 Mar; 20():23-30. PubMed ID: 24412314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct costs of carcinoid syndrome diarrhea among adults in the United States.
    Dasari A; Joish VN; Perez-Olle R; Dharba S; Balaji K; Halperin DM
    World J Gastroenterol; 2019 Dec; 25(47):6857-6865. PubMed ID: 31885426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.